New drug aims to clear hepatitis b in HIV patients
NCT ID NCT06497504
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called bepirovirsen in 153 people who have both HIV and chronic hepatitis B and are already on HIV treatment. The goal is to see if bepirovirsen can clear the hepatitis B virus from the body better than a placebo. Participants will continue their regular HIV medications throughout the study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Bakersfield, California, 93301, United States
-
GSK Investigational Site
San Francisco, California, 94115, United States
-
GSK Investigational Site
Orlando, Florida, 32803, United States
-
GSK Investigational Site
West Palm Beach, Florida, 33409, United States
-
GSK Investigational Site
Baltimore, Maryland, 21287, United States
-
GSK Investigational Site
Minneapolis, Minnesota, 55415, United States
-
GSK Investigational Site
Hillsborough, New Jersey, 08844, United States
-
GSK Investigational Site
Almagro, C1427CEA, Argentina
-
GSK Investigational Site
Buenos Aires, 1023, Argentina
-
GSK Investigational Site
Buenos Aires, C1181ACI, Argentina
-
GSK Investigational Site
Buenos Aires, C1425AGC, Argentina
-
GSK Investigational Site
La Plata, B1900AVG, Argentina
-
GSK Investigational Site
Rosario, S2002KDR, Argentina
-
GSK Investigational Site
Aracaju, 49060-010, Brazil
-
GSK Investigational Site
Campinas, 13034-685, Brazil
-
GSK Investigational Site
Curitiba, 80810-050, Brazil
-
GSK Investigational Site
Manaus, 69040-000, Brazil
-
GSK Investigational Site
Salvador, 40110-060, Brazil
-
GSK Investigational Site
São Paulo, 04121-000, Brazil
-
GSK Investigational Site
Ottawa, Ontario, K1H 8L6, Canada
-
GSK Investigational Site
Toronto, Ontario, M5G 1K2, Canada
-
GSK Investigational Site
Montreal, Quebec, H2L 4P9, Canada
-
GSK Investigational Site
Montreal, Quebec, H4A 3J1, Canada
-
GSK Investigational Site
Québec, Quebec, G1V 4G2, Canada
-
GSK Investigational Site
Marseille, 13003, France
-
GSK Investigational Site
Melun, 77000, France
-
GSK Investigational Site
Montpellier, 34295, France
-
GSK Investigational Site
Nantes, 44093, France
-
GSK Investigational Site
Paris, 75012, France
-
GSK Investigational Site
Paris, 75018, France
-
GSK Investigational Site
Genova, 16132, Italy
-
GSK Investigational Site
Milan, 20157, Italy
-
GSK Investigational Site
Milan, 20162, Italy
-
GSK Investigational Site
Naples, 80131, Italy
-
GSK Investigational Site
Roma, 00153, Italy
-
GSK Investigational Site
Sassari, 07100, Italy
-
GSK Investigational Site
Durban, 4052, South Africa
-
GSK Investigational Site
Johannesburg, 2092, South Africa
-
GSK Investigational Site
Reiger Park, 1459, South Africa
-
GSK Investigational Site
Barcelona, 08036, Spain
-
GSK Investigational Site
Córdoba, 14004, Spain
-
GSK Investigational Site
Madrid, 28032, Spain
-
GSK Investigational Site
Madrid, 28040, Spain
-
GSK Investigational Site
Madrid, 28041, Spain
-
GSK Investigational Site
Madrid, 28046, Spain
-
GSK Investigational Site
Banchiau Taipei, 220, Taiwan
-
GSK Investigational Site
Kaohsiung City, 813, Taiwan
-
GSK Investigational Site
Bristol Avon, BS10 5NB, United Kingdom
-
GSK Investigational Site
London, E1 1BB, United Kingdom
-
GSK Investigational Site
London, NW3 2QG, United Kingdom
-
GSK Investigational Site
London, SE5 9RS, United Kingdom